Finally, we measured the levels of intracellular IFNγ and TNFα cytokines, MIP-1β chemokine, and CD107a degranulation marker expressed by NK cells in the PBMCs from the CLL patients after exposure to K562 and treatment with IL15 or scFvB1IL15. This evidence concerns the gene IL15 and B-cell chronic lymphocytic leukemia.